Application Sponsors
ANDA 091656 | CADILA PHARMS LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 200MG | 0 | OFLOXACIN | OFLOXACIN |
002 | TABLET;ORAL | 300MG | 0 | OFLOXACIN | OFLOXACIN |
003 | TABLET;ORAL | 400MG | 0 | OFLOXACIN | OFLOXACIN |
FDA Submissions
N/A; Not Applicable | ORIG | 1 | AP | 2014-09-18 | |
LABELING; Labeling | SUPPL | 2 | AP | 2016-07-26 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2018-10-18 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2019-10-16 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 42 |
SUPPL | 2 | Null | 15 |
SUPPL | 4 | Null | 31 |
SUPPL | 5 | Null | 15 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
CADILA PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 91656
[companyName] => CADILA PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"OFLOXACIN","activeIngredients":"OFLOXACIN","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OFLOXACIN","activeIngredients":"OFLOXACIN","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OFLOXACIN","activeIngredients":"OFLOXACIN","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"OFLOXACIN","submission":"OFLOXACIN","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OFLOXACIN","submission":"OFLOXACIN","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OFLOXACIN","submission":"OFLOXACIN","actionType":"400MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)